Euroopan unioni - englanti - EMA (European Medicines Agency)

intervet international bv - estriol - sex hormones and modulators of the genital system - dogs - the treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in ovariohysterectomised bitches.

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - estriol - vaginal cream - 1mg/1gram

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - ethinylestradiol - oral tablet - 1mg

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

besins healthcare (uk) ltd - estriol - pessary - 0.03 milligram - natural and semisynthetic estrogens, plain

Yhdistynyt kuningaskunta - englanti - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - estriol - tablet - hormone sex - dogs

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

pco manufacturing - estradiol hemihydrate - vaginal tablets - 10 microgram - natural and semisynthetic estrogens, plain

Israel - englanti - Ministry of Health

cts ltd - estradiol - gel - estradiol 0.06 %w/w - estradiol - estradiol - hormonal replacement therapy for the treatment of symptoms associated with estrogen deficiency in menopausal women. prevention of postmenopausal osteoporosis in women with an increased risk for osteoporotic fractures and presenting intolerace or a contraindication to others treatments indicated in the prevention of osteoporosis.

Israel - englanti - Ministry of Health

novo nordisk ltd., israel - estradiol hemihydrate - film coated tablets - estradiol hemihydrate 10 mcg - estradiol - estradiol - treatment of atrophic vaginitis due to estrogen deficiency in postmenopausal women.the experience treating women older than 65 years is limited.שינוי משטר מינון: 1/7/2019שינויים בעלון לרופא בסעיף posology:4.2 posology and method of administrationvagifem is administered intravaginally as a local oestrogen therapy by use of an applicator. initial dose: one vaginal tablet daily for two weeks. maintenance dose: one vaginal tablet twice a week.treatment may be started on any convenient day.if a dose is forgotten, it should be taken as soon as the patient remembers. a double dose should be avoided.for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also section 4.4) should be used.for oestrogen products for vaginal application of which the systemic exposure to the oestrogen remains within the normal postmenopausal range, such as vagifem, it is not recommended to add a progestagen (but see section 4.4, ‘special warnings and precautions for use’, ‘endometrial hyperplasia and carcinoma’).

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - estradiol hemihydrate - transdermal patch - 50 microgram/day - natural and semisynthetic estrogens, plain

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - estradiol hemihydrate - transdermal patch - 25 microgram/day - natural and semisynthetic estrogens, plain